Header Logo

Connection

RUBEN HERNAEZ to Humans

Back to Details
This is a "connection" page, showing publications RUBEN HERNAEZ has written about Humans.
RUBEN HERNAEZ
Connection Strength
0.704
Humans
  1. Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial. Gut. 2024 Nov 11; 73(12):2037-2044.
    View in: PubMed
    Score: 0.019
  2. Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity? Gut. 2024 04 05; 73(5):721-724.
    View in: PubMed
    Score: 0.018
  3. Breathing new life to posttransplant survival models. Liver Transpl. 2024 Jul 01; 30(7):673-675.
    View in: PubMed
    Score: 0.018
  4. Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review. Saudi J Gastroenterol. 2024 Jan 01; 30(1):14-22.
    View in: PubMed
    Score: 0.018
  5. Telehealth interventions in patients with chronic liver diseases: A systematic review. Hepatology. 2023 07 01; 78(1):179-194.
    View in: PubMed
    Score: 0.017
  6. Dietary Interventions for Gastroparesis: A Systematic Review. Adv Nutr. 2022 10 02; 13(5):1715-1724.
    View in: PubMed
    Score: 0.017
  7. Outcomes of Exercise Interventions in Patients With Advanced Liver Disease: A Systematic Review of Randomized Clinical Trials. Am J Gastroenterol. 2022 10 01; 117(10):1614-1620.
    View in: PubMed
    Score: 0.016
  8. Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: cui bono? Gut. 2023 01; 72(1):7-9.
    View in: PubMed
    Score: 0.016
  9. MAFLD, HCC and the dilemma of (changing) terminology in liver diseases. Gut. 2023 01; 72(1):9-11.
    View in: PubMed
    Score: 0.016
  10. Proposing a Framework to Assess the Methodological Quality of Prognostic Models. Liver Transpl. 2022 04; 28(4):544-546.
    View in: PubMed
    Score: 0.016
  11. Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance. Clin Gastroenterol Hepatol. 2022 12; 20(12):2818-2825.e1.
    View in: PubMed
    Score: 0.016
  12. Systematic review: hepatitis C viraemic allografts to hepatitis C-negative recipients in solid organ transplantation. Aliment Pharmacol Ther. 2021 09; 54(5):571-582.
    View in: PubMed
    Score: 0.015
  13. Serum testosterone levels and testosterone supplementation in cirrhosis: A systematic review. Liver Int. 2021 10; 41(10):2358-2370.
    View in: PubMed
    Score: 0.015
  14. End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma. Gut. 2022 03; 71(3):454-456.
    View in: PubMed
    Score: 0.015
  15. Reply to: "The role of the model for end-stage liver disease sodium score and joint models for 90-day mortality prediction in in patients with acute-on-chronic liver failure". J Hepatol. 2021 02; 74(2):477.
    View in: PubMed
    Score: 0.015
  16. Reply to: "Model for end-stage liver disease-sodium in acute-on-chronic liver failure". J Hepatol. 2020 12; 73(6):1579-1580.
    View in: PubMed
    Score: 0.014
  17. Considerations for Prognosis, Goals of Care, and Specialty Palliative Care for Hospitalized Patients With Acute-on-Chronic Liver Failure. Hepatology. 2020 09; 72(3):1109-1116.
    View in: PubMed
    Score: 0.014
  18. Depression and Anxiety Are Common Among Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022 01; 20(1):194-203.e1.
    View in: PubMed
    Score: 0.014
  19. Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 05; 19(5):987-995.e1.
    View in: PubMed
    Score: 0.014
  20. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. J Hepatol. 2020 12; 73(6):1425-1433.
    View in: PubMed
    Score: 0.014
  21. Duodenal and liver lesions in an adult with generalised weakness. Gut. 2020 09; 69(9):1-2.
    View in: PubMed
    Score: 0.013
  22. Reply to: "Prevalence and short-term mortality in a national US cohort with acute-on-chronic liver failure". J Hepatol. 2019 09; 71(3):638-639.
    View in: PubMed
    Score: 0.013
  23. Reply to: "Mortality of acute-on-chronic liver failure: What is the role of obesity?" J Hepatol. 2019 06; 70(6):1301-1302.
    View in: PubMed
    Score: 0.013
  24. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. J Hepatol. 2019 04; 70(4):639-647.
    View in: PubMed
    Score: 0.013
  25. Risk of Bias Analysis of Systematic Reviews of Probiotics for Treatment of Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2019 03; 17(4):784-785.
    View in: PubMed
    Score: 0.012
  26. Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis. Hepatology. 2018 07; 68(1):7-9.
    View in: PubMed
    Score: 0.012
  27. How we approach it: treatment options for hepatocellular carcinoma. Am J Gastroenterol. 2018 06; 113(6):791-794.
    View in: PubMed
    Score: 0.012
  28. High Negative Predictive Value, Low Prevalence, and Spectrum Effect: Caution in the Interpretation. Clin Gastroenterol Hepatol. 2017 09; 15(9):1355-1358.
    View in: PubMed
    Score: 0.011
  29. Hepatocellular carcinoma surveillance: The road ahead. Hepatology. 2017 03; 65(3):771-773.
    View in: PubMed
    Score: 0.011
  30. Acute-on-chronic liver failure: an update. Gut. 2017 03; 66(3):541-553.
    View in: PubMed
    Score: 0.011
  31. ?Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study. Ann Hepatol. 2017 Jan-Feb 2017; 16(1):16-20.
    View in: PubMed
    Score: 0.011
  32. Reliability and agreement studies: a guide for clinical investigators. Gut. 2015 Jul; 64(7):1018-27.
    View in: PubMed
    Score: 0.010
  33. Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagitis. Aliment Pharmacol Ther. 2015 May; 41(9):797-806.
    View in: PubMed
    Score: 0.010
  34. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013 Aug; 38(3):246-54.
    View in: PubMed
    Score: 0.009
  35. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2013 Sep; 11(9):1183-1190.e2.
    View in: PubMed
    Score: 0.008
  36. Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. Gastroenterol Hepatol. 2012 Jan; 35(1):32-41.
    View in: PubMed
    Score: 0.008
  37. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011 Sep 02; 54(3):1082-1090.
    View in: PubMed
    Score: 0.008
  38. Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2011 Nov; 55(5):1079-85.
    View in: PubMed
    Score: 0.007
  39. Concomitant hiatal hernia repair with transoral incisionless fundoplication for the treatment of refractory gastroesophageal reflux disease: a systematic review. Surg Endosc. 2024 Oct; 38(10):5528-5540.
    View in: PubMed
    Score: 0.005
  40. Self-Correcting Method for Highly Effective Office-Based Helicobacter pylori Therapy Using Cumulative Test of Cure Data. Helicobacter. 2024 Jul-Aug; 29(4):e13112.
    View in: PubMed
    Score: 0.005
  41. Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2024 Nov 01; 119(11):2259-2266.
    View in: PubMed
    Score: 0.005
  42. Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers. Gut. 2024 05 10; 73(6):1015-1024.
    View in: PubMed
    Score: 0.005
  43. Postoperative outcomes of acute-on-chronic liver failure in infants and children with biliary atresia. Pediatr Transplant. 2024 May; 28(3):e14736.
    View in: PubMed
    Score: 0.005
  44. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis. Gut. 2023 12 07; 73(1):156-165.
    View in: PubMed
    Score: 0.004
  45. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
    View in: PubMed
    Score: 0.004
  46. Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass. Oncology (Williston Park). 2023 08 08; 37(8):335-338.
    View in: PubMed
    Score: 0.004
  47. Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2024 Apr; 22(4):760-767.e1.
    View in: PubMed
    Score: 0.004
  48. Plasma exchange for acute and acute-on-chronic liver failure: A systematic review and meta-analysis. Liver Transpl. 2024 02 01; 30(2):127-141.
    View in: PubMed
    Score: 0.004
  49. Behavioral weight-loss interventions for patients with NAFLD: A systematic scoping review. Hepatol Commun. 2023 08 01; 7(8).
    View in: PubMed
    Score: 0.004
  50. Improving Adherence to Clinical Practice Guidelines for Managing Gastric Intestinal Metaplasia Among Gastroenterologists at a US Academic Institution. J Clin Gastroenterol. 2024 May-Jun 01; 58(5):432-439.
    View in: PubMed
    Score: 0.004
  51. Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis. Hepatology. 2024 01 01; 79(1):107-117.
    View in: PubMed
    Score: 0.004
  52. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727.
    View in: PubMed
    Score: 0.004
  53. Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. Liver Transpl. 2023 10 01; 29(10):1138-1142.
    View in: PubMed
    Score: 0.004
  54. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology. 2022 11; 163(5):1198-1225.
    View in: PubMed
    Score: 0.004
  55. Assessment of donor quality and risk of graft failure after liver transplantation: The ID2 EAL score. Am J Transplant. 2022 12; 22(12):2921-2930.
    View in: PubMed
    Score: 0.004
  56. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Dig Dis Sci. 2023 01; 68(1):312-322.
    View in: PubMed
    Score: 0.004
  57. Using Telemedicine to Facilitate Patient Communication and Treatment Decision-Making Following Multidisciplinary Tumor Board Review for Patients with Hepatocellular Carcinoma. J Gastrointest Cancer. 2023 Jun; 54(2):623-631.
    View in: PubMed
    Score: 0.004
  58. Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 12; 20(12):2848-2857.e2.
    View in: PubMed
    Score: 0.004
  59. The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol. 2023 02; 21(2):415-423.e4.
    View in: PubMed
    Score: 0.004
  60. Marginal allografts in liver transplantation have a limited impact on length of stay. Clin Transplant. 2022 03; 36(3):e14544.
    View in: PubMed
    Score: 0.004
  61. Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy. Gut. 2022 03; 71(3):643-650.
    View in: PubMed
    Score: 0.004
  62. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
    View in: PubMed
    Score: 0.004
  63. Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans. Microb Ecol. 2022 Apr; 83(3):811-821.
    View in: PubMed
    Score: 0.004
  64. Factors Associated With Access to and Receipt of Liver Transplantation in Veterans With End-stage Liver Disease. JAMA Intern Med. 2021 07 01; 181(7):949-959.
    View in: PubMed
    Score: 0.004
  65. Reply to: "Acute-on-chronic liver failure in East-Asia: an underestimated issue with limited data". Gut. 2022 03; 71(3):657-658.
    View in: PubMed
    Score: 0.004
  66. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation. Contemp Clin Trials. 2021 05; 104:106367.
    View in: PubMed
    Score: 0.004
  67. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut. 2022 01; 71(1):148-155.
    View in: PubMed
    Score: 0.004
  68. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Dig Liver Dis. 2021 06; 53(6):738-745.
    View in: PubMed
    Score: 0.004
  69. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol. 2021 01; 74(1):200-219.
    View in: PubMed
    Score: 0.004
  70. Interaction Between Alcohol Consumption and PNPLA3 Variant in the Prevalence of Hepatic Steatosis in the US Population. Clin Gastroenterol Hepatol. 2021 12; 19(12):2606-2614.e4.
    View in: PubMed
    Score: 0.004
  71. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 01; 19(1):61-71.e15.
    View in: PubMed
    Score: 0.003
  72. Antitumour necrosis factor-a agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort. BMJ Open Gastroenterol. 2020; 7(1):e000349.
    View in: PubMed
    Score: 0.003
  73. Renal Trajectory Patterns Are Associated With Postdischarge Mortality in Patients With Cirrhosis and Acute Kidney Injury. Clin Gastroenterol Hepatol. 2020 07; 18(8):1858-1866.e6.
    View in: PubMed
    Score: 0.003
  74. Dietary quality and the colonic mucosa-associated gut microbiome in humans. Am J Clin Nutr. 2019 09 01; 110(3):701-712.
    View in: PubMed
    Score: 0.003
  75. Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 04; 18(4):974-983.
    View in: PubMed
    Score: 0.003
  76. Recommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care. Clin Gastroenterol Hepatol. 2020 02; 18(2):276-289.e2.
    View in: PubMed
    Score: 0.003
  77. Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon. Nutrients. 2019 Mar 13; 11(3).
    View in: PubMed
    Score: 0.003
  78. Gastroesophageal reflux after peroral endoscopic myotomy: a multicenter case-control study. Endoscopy. 2017 Jul; 49(7):634-642.
    View in: PubMed
    Score: 0.003
  79. Efficacy and Safety of Peroral Endoscopic Myotomy for Treatment of Achalasia After Failed Heller Myotomy. Clin Gastroenterol Hepatol. 2017 Oct; 15(10):1531-1537.e3.
    View in: PubMed
    Score: 0.003
  80. Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis. Ann Surg. 2017 01; 265(1):20-29.
    View in: PubMed
    Score: 0.003
  81. Ileus is a predictor of local infection in patients with acute necrotizing pancreatitis. Pancreatology. 2016 Nov - Dec; 16(6):966-972.
    View in: PubMed
    Score: 0.003
  82. Endoscopic suturing for the prevention of stent migration in benign upper gastrointestinal conditions: a comparative multicenter study. Endoscopy. 2016 Sep; 48(9):802-8.
    View in: PubMed
    Score: 0.003
  83. Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis. Gut. 2017 08; 66(8):1390-1397.
    View in: PubMed
    Score: 0.003
  84. Nonalcoholic fatty liver disease is associated with cognitive function in adults. Neurology. 2016 Mar 22; 86(12):1136-42.
    View in: PubMed
    Score: 0.003
  85. Patients Receiving Prebiotics and Probiotics Before Liver Transplantation Develop Fewer Infections Than Controls: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1567-74.e3; quiz e143-4.
    View in: PubMed
    Score: 0.002
  86. Controversy on the time to progression of pancreatic ductal adenocarcinoma. Gut. 2015 Nov; 64(11):1676-7.
    View in: PubMed
    Score: 0.002
  87. Early versus on-demand tube feeding in pancreatitis. N Engl J Med. 2015 02 12; 372(7):684.
    View in: PubMed
    Score: 0.002
  88. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. Hepatology. 2013 Sep; 58(3):966-75.
    View in: PubMed
    Score: 0.002
  89. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2013 Jul 01; 178(1):38-45.
    View in: PubMed
    Score: 0.002
  90. Association between serum uric acid and nonalcoholic fatty liver disease in the US population. J Formos Med Assoc. 2015 Apr; 114(4):314-20.
    View in: PubMed
    Score: 0.002
  91. Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III. J Gastroenterol. 2013 Oct; 48(10):1151-9.
    View in: PubMed
    Score: 0.002
  92. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ. 2011 Nov 18; 343:d6891.
    View in: PubMed
    Score: 0.002
  93. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011 Mar; 7(3):e1001324.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.